A retrospective cohort study found that patients undergoing outpatient GI procedures who received opioids intra- or post-operatively reported lower pain scores and fewer instances of postoperative nausea...
In an FDA panel held on July 21, 2025, experts discussed the nuances of risk-benefit counseling and stronger warnings for selective serotonin reuptake inhibitors (SSRIs) to ensure informed consent among...
A study presented at American Podiatric Medical Association 2025 Annual Scientific Meeting explores how pain severity shapes daily burden, treatment experiences, and trial preferences among individuals...
Adding subcutaneous insulin degludec early to IV insulin may accelerate diabetic ketoacidosis resolution and improve glycemic outcomes without added risk.
A randomized, double-blind, placebo-controlled crossover study found that a single 300 mg dose of palmitoylethanolamide significantly reduced acute menstrual pain compared with placebo at multiple early...
In this expert interview, Tugce Akcan, MD, discusses a novel approach to type 1 diabetes care using OpenAPS and GLP-1 receptor agonists to eliminate the need for prandial insulin boluses and improve patient...
A phase 2 study evaluating the safety and efficacy of letrozole, abemaciclib, and metformin in treating estrogen receptor–positive recurrent endometrial cancer highlights promising outcomes in a select...
A post hoc analysis of the DUO-E trial evaluated how durvalumab and maintenance olaparib influenced circulating tumor DNA dynamics in first-line endometrial cancer treatment.
